Brind.

Twist Bioscience launched an Oncology DNA Comprehensive Genomic Profiling (CGP) Panel on August 19, 2025.

1 report, 1 independent Updated Aug 19

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Twist Bioscience

Keep exploring

The entities involved

Twist Bioscience
Biotechnology company
- ISI (Twist Bioscience) was listed on the Nasdaq stock exchange, and Barclays raised its price target on the company on July 9, 2026.Fri 14:20

Coverage

Newest first; wire copies grouped

Aug 19Business WireTwist Bioscience Launches Oncology DNA CGP Panel to Advance Precision Medicine with Customizable, Platform-Agnostic NGS Solution SOUTH SAN FRANCISCO, Calif., August 19, 2025--(BUSINESS WIRE)--Twist B